PWA
PTCT icon

Physician Wealth Advisors’s PTC Therapeutics PTCT Stock Holding History

Physician Wealth Advisors’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$614 Buy
9
+5
+125% +$354 ﹤0.01% 1848
2025
Q4 		$304 Buy
+4
New +$291 ﹤0.01% 1980
2025
Q3 		– Sell
-22
Closed -$1.07K – 2019
2025
Q2 		$1.07K Buy
+22
New +$1.04K ﹤0.01% 1375

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Physician Wealth Advisors's PTCT Position: Q1 2026 in Review

Physician Wealth Advisors increased its PTC Therapeutics (PTCT) stake by 125% in Q1 2026, buying an estimated $354 and bringing the position to 9 shares worth $614. The position accounts for ﹤0.01% of the portfolio, ranked #1848.

Physician Wealth Advisors first reported a position in PTCT in Q2 2025 and has held it in 3 quarters since. The position peaked at $1.07K in Q2 2025. 349 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Physician Wealth Advisors held 9 shares of PTC Therapeutics worth $614 as of Q1 2026.
  • Physician Wealth Advisors bought 5 PTC Therapeutics shares in Q1 2026, an estimated $354.
  • PTC Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q1 2026, its #1848 holding.
  • Physician Wealth Advisors first reported a position in PTC Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • Physician Wealth Advisors's PTC Therapeutics position peaked at $1.07K in Q2 2025.
  • 349 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Physician Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.